Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 23.80M | $ 54.30M | $ 8.40M | $ 4.20M | $ 40.40M |
Total Assets | $ 2.54B | $ 2.53B | $ 2.31B | $ 2.27B | $ 2.34B |
Total Debt | $ 361.50M | $ 339.30M | $ 353.40M | $ 336.90M | $ 443.50M |
Net Debt | $ 337.70M | $ 285.00M | $ 345.00M | $ 332.70M | $ 403.10M |
Total Liabilities | $ 1.01B | $ 1.03B | $ 1.09B | $ 1.09B | $ 1.21B |
Stockholders Equity | $ 1.52B | $ 1.51B | $ 1.21B | $ 1.18B | $ 1.13B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |